PALONOSETRON HYDROCHLORIDE
| Brand name | ALOXI |
|---|---|
| Active ingredient | PALONOSETRON HYDROCHLORIDE |
| Strength | EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** |
| Dosage form | INJECTABLE |
| Route | INTRAVENOUS |
| Modality | Small molecule |
| FDA approval | July 2003 |
| Marketing status | DISCN |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.